1,2-dimethylhydrazine multiple interactions EXP 6480464 [APC protein affects the susceptibility to 1, 2-Dimethylhydrazine] which results in decreased expression of ABI3BP mRNA CTD PMID:27840820 17beta-estradiol decreases expression ISO RGD:1616439 6480464 Estradiol results in decreased expression of ABI3BP mRNA CTD PMID:19484750 17beta-estradiol multiple interactions EXP 6480464 [estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of ABI3BP mRNA CTD PMID:32741896 17beta-estradiol 3-benzoate multiple interactions EXP 6480464 [estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of ABI3BP mRNA CTD PMID:32741896 2,3,7,8-tetrachlorodibenzodioxine affects expression ISO RGD:1616439 6480464 Tetrachlorodibenzodioxin affects the expression of ABI3BP mRNA CTD PMID:21570461 2,3,7,8-tetrachlorodibenzodioxine increases expression EXP 6480464 Tetrachlorodibenzodioxin results in increased expression of ABI3BP mRNA CTD PMID:34747641 2,3,7,8-tetrachlorodibenzodioxine decreases expression EXP 6480464 Tetrachlorodibenzodioxin results in decreased expression of ABI3BP mRNA CTD PMID:32109520 , PMID:33387578 2,3,7,8-tetrachlorodibenzodioxine decreases expression ISO RGD:1616439 6480464 Tetrachlorodibenzodioxin results in decreased expression of ABI3BP mRNA CTD PMID:26290441 2,3,7,8-tetrachlorodibenzodioxine multiple interactions ISO RGD:1349467 6480464 Endosulfan inhibits the reaction [Tetrachlorodibenzodioxin results in decreased expression of ABI3BP mRNA] CTD PMID:26159488 2,3,7,8-tetrachlorodibenzodioxine decreases expression ISO RGD:1349467 6480464 Tetrachlorodibenzodioxin results in decreased expression of ABI3BP mRNA CTD PMID:20106945 , PMID:26159488 3,4-methylenedioxymethamphetamine decreases expression ISO RGD:1616439 6480464 N-Methyl-3, 4-methylenedioxyamphetamine results in decreased expression of ABI3BP mRNA CTD PMID:26251327 3-isobutyl-1-methyl-7H-xanthine multiple interactions ISO RGD:1349467 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin] results in decreased expression of ABI3BP mRNA CTD PMID:28628672 3-methylcholanthrene decreases expression ISO RGD:1616439 6480464 Methylcholanthrene results in decreased expression of ABI3BP mRNA CTD PMID:20713471 3-Nitrobenzanthrone increases expression ISO RGD:1349467 6480464 3-nitrobenzanthrone results in increased expression of ABI3BP mRNA CTD PMID:34036453 4,4'-sulfonyldiphenol increases expression ISO RGD:1616439 6480464 bis(4-hydroxyphenyl)sulfone results in increased expression of ABI3BP mRNA CTD PMID:30951980 4-hydroxyphenyl retinamide decreases expression ISO RGD:1616439 6480464 Fenretinide results in decreased expression of ABI3BP mRNA CTD PMID:28973697 aristolochic acid A decreases expression ISO RGD:1349467 6480464 aristolochic acid I results in decreased expression of ABI3BP mRNA CTD PMID:33212167 arsane multiple interactions ISO RGD:1349467 6480464 [sodium arsenate results in increased abundance of Arsenic] which results in increased expression of ABI3BP mRNA CTD PMID:32525701 arsenic atom multiple interactions ISO RGD:1349467 6480464 [sodium arsenate results in increased abundance of Arsenic] which results in increased expression of ABI3BP mRNA CTD PMID:32525701 arsenite(3-) multiple interactions ISO RGD:1349467 6480464 arsenite inhibits the reaction [G3BP1 protein binds to ABI3BP mRNA] CTD PMID:32406909 atrazine affects methylation EXP 6480464 Atrazine affects the methylation of ABI3BP gene CTD PMID:28931070 benzo[a]pyrene decreases expression ISO RGD:1616439 6480464 Benzo(a)pyrene results in decreased expression of ABI3BP mRNA CTD PMID:20713471 , PMID:21569818 benzo[a]pyrene increases methylation ISO RGD:1616439 6480464 Benzo(a)pyrene results in increased methylation of ABI3BP intron, Benzo(a)pyrene results in increased methylation of ABI3BP promoter CTD PMID:27901495 benzo[a]pyrene decreases methylation ISO RGD:1349467 6480464 Benzo(a)pyrene results in decreased methylation of ABI3BP 5' UTR CTD PMID:27901495 benzo[a]pyrene multiple interactions ISO RGD:1616439 6480464 [Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of ABI3BP mRNA CTD PMID:27858113 benzo[a]pyrene decreases expression EXP 6480464 Benzo(a)pyrene results in decreased expression of ABI3BP mRNA CTD PMID:21839799 benzo[a]pyrene decreases expression ISO RGD:1349467 6480464 Benzo(a)pyrene results in decreased expression of ABI3BP mRNA CTD PMID:20106945 benzo[b]fluoranthene multiple interactions ISO RGD:1616439 6480464 [Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of ABI3BP mRNA CTD PMID:27858113 bisphenol A decreases expression EXP 6480464 bisphenol A results in decreased expression of ABI3BP mRNA CTD PMID:25181051 bisphenol A multiple interactions ISO RGD:1349467 6480464 [bisphenol A co-treated with Fulvestrant] results in increased methylation of ABI3BP gene CTD PMID:31601247 bisphenol A increases expression ISO RGD:1616439 6480464 bisphenol A results in increased expression of ABI3BP mRNA CTD PMID:30951980 bisphenol A increases expression ISO RGD:1349467 6480464 bisphenol A results in increased expression of ABI3BP mRNA CTD PMID:27685785 bisphenol F increases expression ISO RGD:1616439 6480464 bisphenol F results in increased expression of ABI3BP mRNA CTD PMID:30951980 butanal decreases expression ISO RGD:1349467 6480464 butyraldehyde results in decreased expression of ABI3BP mRNA CTD PMID:26079696 cadmium atom multiple interactions ISO RGD:1349467 6480464 [Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of ABI3BP mRNA CTD PMID:35301059 cadmium dichloride multiple interactions ISO RGD:1349467 6480464 [Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of ABI3BP mRNA CTD PMID:35301059 calcitriol decreases expression ISO RGD:1349467 6480464 Calcitriol results in decreased expression of ABI3BP mRNA CTD PMID:26485663 carbon nanotube decreases expression ISO RGD:1616439 6480464 Nanotubes more ... CTD PMID:25554681 CGP 52608 multiple interactions ISO RGD:1349467 6480464 CGP 52608 promotes the reaction [RORA protein binds to ABI3BP gene] CTD PMID:28238834 chromium atom decreases expression ISO RGD:1349467 6480464 Chromium results in decreased expression of ABI3BP mRNA CTD PMID:21437242 chrysene increases expression ISO RGD:1616439 6480464 chrysene results in increased expression of ABI3BP mRNA CTD PMID:26377693 chrysene multiple interactions ISO RGD:1616439 6480464 [Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of ABI3BP mRNA CTD PMID:27858113 clothianidin decreases expression ISO RGD:1349467 6480464 clothianidin results in decreased expression of ABI3BP mRNA CTD PMID:31626844 crocidolite asbestos decreases expression ISO RGD:1616439 6480464 Asbestos, Crocidolite results in decreased expression of ABI3BP mRNA CTD PMID:29279043 cyclosporin A decreases expression ISO RGD:1349467 6480464 Cyclosporine results in decreased expression of ABI3BP mRNA CTD PMID:20106945 dexamethasone multiple interactions ISO RGD:1349467 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin] results in decreased expression of ABI3BP mRNA CTD PMID:28628672 dibenz[a,h]anthracene decreases expression ISO RGD:1616439 6480464 1 more ... CTD PMID:26377693 dibutyl phthalate decreases expression ISO RGD:1616439 6480464 Dibutyl Phthalate results in decreased expression of ABI3BP mRNA CTD PMID:21266533 dioxygen multiple interactions ISO RGD:1616439 6480464 [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of ABI3BP mRNA CTD PMID:30529165 dioxygen multiple interactions EXP 6480464 [Oxygen deficiency co-treated with Blood Glucose deficiency co-treated with Particulate Matter] results in decreased expression of ABI3BP mRNA CTD PMID:33729688 diuron decreases expression EXP 6480464 Diuron results in decreased expression of ABI3BP mRNA CTD PMID:25152437 diuron increases expression EXP 6480464 Diuron results in increased expression of ABI3BP mRNA CTD PMID:21551480 doxorubicin decreases expression ISO RGD:1349467 6480464 Doxorubicin results in decreased expression of ABI3BP mRNA CTD PMID:29803840 endosulfan multiple interactions ISO RGD:1349467 6480464 Endosulfan inhibits the reaction [Tetrachlorodibenzodioxin results in decreased expression of ABI3BP mRNA] CTD PMID:26159488 endosulfan decreases expression EXP 6480464 Endosulfan results in decreased expression of ABI3BP mRNA CTD PMID:29391264 epoxiconazole decreases expression ISO RGD:1616439 6480464 epoxiconazole results in decreased expression of ABI3BP mRNA CTD PMID:35436446 ethanol decreases expression ISO RGD:1616439 6480464 Ethanol results in decreased expression of ABI3BP mRNA CTD PMID:29018328 ethanol increases expression ISO RGD:1616439 6480464 Ethanol results in increased expression of ABI3BP mRNA CTD PMID:30319688 ethanol affects expression ISO RGD:1616439 6480464 Ethanol affects the expression of ABI3BP mRNA CTD PMID:30319688 fenofibrate decreases expression ISO RGD:1349467 6480464 Fenofibrate results in decreased expression of ABI3BP mRNA CTD PMID:25572481 formaldehyde increases expression ISO RGD:1349467 6480464 Formaldehyde results in increased expression of ABI3BP mRNA CTD PMID:23649840 , PMID:28937961 fulvestrant multiple interactions ISO RGD:1349467 6480464 [bisphenol A co-treated with Fulvestrant] results in increased methylation of ABI3BP gene CTD PMID:31601247 glycine betaine increases expression EXP 6480464 Betaine results in increased expression of ABI3BP mRNA CTD PMID:26391144 GW 4064 decreases expression ISO RGD:1616439 6480464 GW 4064 results in decreased expression of ABI3BP mRNA CTD PMID:26655953 indometacin multiple interactions ISO RGD:1349467 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin] results in decreased expression of ABI3BP mRNA CTD PMID:28628672 N-nitrosodiethylamine multiple interactions ISO RGD:1616439 6480464 [Diethylnitrosamine co-treated with Phenobarbital] results in decreased expression of ABI3BP mRNA CTD PMID:24535843 N-nitrosodiethylamine increases expression ISO RGD:1616439 6480464 Diethylnitrosamine results in increased expression of ABI3BP mRNA CTD PMID:24535843 nickel sulfate increases expression ISO RGD:1349467 6480464 nickel sulfate results in increased expression of ABI3BP mRNA CTD PMID:22714537 oxaliplatin increases expression EXP 6480464 oxaliplatin results in increased expression of ABI3BP mRNA CTD PMID:25729387 oxaliplatin multiple interactions EXP 6480464 [oxaliplatin co-treated with Topotecan] results in increased expression of ABI3BP mRNA CTD PMID:25729387 ozone multiple interactions ISO RGD:1616439 6480464 [Air Pollutants results in increased abundance of [Ozone co-treated with Soot]] which results in decreased expression of ABI3BP mRNA, [Air Pollutants results in increased abundance of Ozone] which results in decreased expression of ABI3BP mRNA CTD PMID:34911549 paracetamol increases expression EXP 6480464 Acetaminophen results in increased expression of ABI3BP mRNA CTD PMID:33387578 phenobarbital multiple interactions ISO RGD:1616439 6480464 [Diethylnitrosamine co-treated with Phenobarbital] results in decreased expression of ABI3BP mRNA CTD PMID:24535843 phenobarbital affects expression ISO RGD:1616439 6480464 Phenobarbital affects the expression of ABI3BP mRNA CTD PMID:19136022 , PMID:23091169 pioglitazone multiple interactions ISO RGD:1616439 6480464 [N-nitroso-tris-chloroethylurea co-treated with pioglitazone] results in decreased expression of ABI3BP mRNA CTD PMID:27935865 pirinixic acid affects expression ISO RGD:1616439 6480464 pirinixic acid affects the expression of ABI3BP mRNA CTD PMID:19136022 pirinixic acid decreases expression ISO RGD:1616439 6480464 pirinixic acid results in decreased expression of ABI3BP mRNA CTD PMID:20813756 potassium chromate decreases expression ISO RGD:1349467 6480464 potassium chromate(VI) results in decreased expression of ABI3BP mRNA CTD PMID:22714537 progesterone increases expression ISO RGD:1349467 6480464 Progesterone results in increased expression of ABI3BP mRNA CTD PMID:20864642 resveratrol multiple interactions ISO RGD:1349467 6480464 [Plant Extracts co-treated with Resveratrol] results in decreased expression of ABI3BP mRNA CTD PMID:23557933 sodium arsenate multiple interactions ISO RGD:1349467 6480464 [sodium arsenate results in increased abundance of Arsenic] which results in increased expression of ABI3BP mRNA CTD PMID:32525701 temozolomide increases expression ISO RGD:1349467 6480464 Temozolomide results in increased expression of ABI3BP mRNA CTD PMID:31758290 testosterone multiple interactions EXP 6480464 [estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of ABI3BP mRNA CTD PMID:32741896 testosterone decreases expression ISO RGD:1349467 6480464 Testosterone results in decreased expression of ABI3BP mRNA CTD PMID:33359661 tetrachloromethane decreases expression ISO RGD:1616439 6480464 Carbon Tetrachloride results in decreased expression of ABI3BP mRNA CTD PMID:17484886 tetrachloromethane decreases expression EXP 6480464 Carbon Tetrachloride results in decreased expression of ABI3BP mRNA CTD PMID:31150632 tetraphene multiple interactions ISO RGD:1616439 6480464 [Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of ABI3BP mRNA CTD PMID:27858113 topotecan multiple interactions EXP 6480464 [oxaliplatin co-treated with Topotecan] results in increased expression of ABI3BP mRNA CTD PMID:25729387 topotecan increases expression EXP 6480464 Topotecan results in increased expression of ABI3BP mRNA CTD PMID:25729387 tremolite asbestos decreases expression ISO RGD:1616439 6480464 tremolite results in decreased expression of ABI3BP mRNA CTD PMID:29279043 triadimefon decreases expression ISO RGD:1349467 6480464 triadimefon results in decreased expression of ABI3BP mRNA CTD PMID:26705709 trichostatin A decreases expression ISO RGD:1349467 6480464 trichostatin A results in decreased expression of ABI3BP mRNA CTD PMID:24935251 trichostatin A increases expression ISO RGD:1349467 6480464 trichostatin A results in increased expression of ABI3BP mRNA CTD PMID:26705709 triclosan increases expression ISO RGD:1349467 6480464 Triclosan results in increased expression of ABI3BP mRNA CTD PMID:30510588 triphenyl phosphate decreases expression EXP 6480464 triphenyl phosphate results in decreased expression of ABI3BP mRNA CTD PMID:30589522 triptonide decreases expression ISO RGD:1616439 6480464 triptonide results in decreased expression of ABI3BP mRNA CTD PMID:33045310 valproic acid affects expression ISO RGD:1616439 6480464 Valproic Acid affects the expression of ABI3BP mRNA CTD PMID:17963808 valproic acid increases expression EXP 6480464 Valproic Acid results in increased expression of ABI3BP mRNA CTD PMID:29427782 valproic acid decreases expression ISO RGD:1349467 6480464 Valproic Acid results in decreased expression of ABI3BP mRNA CTD PMID:24935251 vinclozolin affects expression EXP 6480464 vinclozolin affects the expression of ABI3BP mRNA CTD PMID:19015723 vinclozolin decreases expression EXP 6480464 vinclozolin results in decreased expression of ABI3BP mRNA CTD PMID:23034163 zoledronic acid decreases expression ISO RGD:1349467 6480464 zoledronic acid results in decreased expression of ABI3BP mRNA CTD PMID:24714768